Effect of a functional single nucleotide polymorphism in the 2′,3′-cyclic nucleotide 3′-phosphodiesterase gene on the expression of oligodendrocyte-related genes in schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 1, 2008, Pages 103-108

  Iwamoto, Kazuya ^a   Ueda, Junko ^a   Bundo, Miki ^a   Nakano, Yoko ^a   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

CNP; Microarray; Oligodendrocyte; Post mortem; Schizophrenia

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE;

ALLELE; ARTICLE; DATA ANALYSIS; DISEASE ASSOCIATION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OLIGODENDROGLIA; PLEIOTROPY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; MYELIN PROTEINS; OLIGODENDROGLIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 39149133614     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01786.x     Document Type: Article

References (33)

1. Hakak Y, Walker JR, Li C et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl Acad. Sci. USA 2001 98 : 4746 4751.
2. Tkachev D, Mimmack ML, Ryan MM et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003 362 : 798 805.
3. Sugai T, Kawamura M, Iritani S et al. Prefrontal abnormality of schizophrenia revealed by DNA microarray: Impact on glial and neurotrophic gene expression. Ann. NY Acad. Sci. 2004 1025 : 84 91.
4. Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J. Neurosci. Res. 2004 77 : 858 866.
5. Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol. Dis. 2006 21 : 531 540.
6. Katsel P, Davis KL, Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study. Schizophr. Res. 2005 79 : 157 173.
7. Katsel P, Davis KL, Gorman JM, Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr. Res. 2005 77 : 241 252.
8. Iwamoto K, Bundo M, Yamada K et al. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 2005 25 : 5376 5381.
9. McCullumsmith RE, Gupta D, Beneyto M et al. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr. Res. 2007 90 : 15 27.
10. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: A study from the Stanley Neuropathology Consortium. Schizophr. Res. 2004 67 : 269 275.
11. Uranova N, Orlovskaya D, Vikhreva O et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 2001 55 : 597 610.
12. Hof PR, Haroutunian V, Friedrich VL et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry 2003 53 : 1075 1085.
13. Davis KL, Stewart DG, Friedman JI et al. White matter changes in schizophrenia: Evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 2003 60 : 443 456.
14. Stewart DG, Davis KL. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia. Int. Rev. Neurobiol. 2004 59 : 381 424.
15. Liu X, Qin W, He G et al. A family-based association study of the MOG gene with schizophrenia in the Chinese population. Schizophr. Res. 2005 73 : 275 280.
16. Wan C, Yang Y, Feng G et al. Polymorphisms of myelin-associated glycoprotein gene are associated with schizophrenia in the Chinese Han population. Neurosci. Lett. 2005 388 : 126 131.
17. Yang YF, Qin W, Shugart YY et al. Possible association of the MAG locus with schizophrenia in a Chinese Han cohort of family trios. Schizophr. Res. 2005 75 : 11 19.
18. Qin W, Gao J, Xing Q et al. A family-based association study of PLP1 and schizophrenia. Neurosci. Lett. 2005 375 : 207 210.
19. Xi ZR, Qin W, Yang YF et al. Transmission disequilibrium analysis of the GSN gene in a cohort of family trios with schizophrenia. Neurosci. Lett. 2004 372 : 200 203.
20. Georgieva L, Moskvina V, Peirce T et al. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc. Natl Acad. Sci. USA 2006 103 : 12 69 12 74.
21. He G, Liu X, Qin W et al. MPZL1/PZR, a novel candidate predisposing schizophrenia in Han Chinese. Mol. Psychiatry 2006 11 : 748 751.
22. Peirce TR, Bray NJ, Williams NM et al. Convergent evidence for 2′,3′-cyclic nucleotide 3′-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch. Gen. Psychiatry 2006 63 : 18 24.
23. Zai G, King N, Wigg K et al. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia. Genes Brain Behav. 2005 4 : 2 9.
24. Usui H, Takahashi N, Saito S et al. The 2′,3′-cyclic nucleotide 3′-phosphodiesterase and oligodendrocyte lineage transcription factor 2 genes do not appear to be associated with schizophrenia in the Japanese population. Schizophr. Res. 2006 88 : 245 250.
25. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum. Genet. 2003 113 : 149 153.
26. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry 2004 9 : 406 416.
27. Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 2005 14 : 241 253.
28. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 2000 44 : 151 155.
29. Iwamoto K, Kato T. Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist 2006 12 : 349 361.
30. Li JZ, Vawter MP, Walsh DM et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum. Mol. Genet. 2004 13 : 609 616.
31. Tomita H, Vawter MP, Walsh DM et al. Effect of agonal and postmortem factors on gene expression profile: Quality control in microarray analyses of postmortem human brain. Biol. Psychiatry 2004 55 : 346 352.
32. Yamaguchi Y, Pfeiffer SE. Highly basic myelin and oligodendrocyte proteins analyzed by NEPHGE-two-dimensional gel electrophoresis: Recognition of novel developmentally regulated proteins. J. Neurosci. Res. 1999 56 : 199 205.
33. Douglas AJ, Thompson RJ. Structure of the myelin membrane enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase: Evidence for two human mRNAs. Biochem. Soc. Trans. 1993 21 : 295 297.